Elsevier,

Journal of Aging Studies, Volume 61, June 2022

An investigation of the support needed for the visually impaired to be able to age successfully.
Background: There are 15·4 million children who are HIV-exposed and uninfected worldwide. Early child development crucially influences later academic and socioeconomic factors.
Financial constraints usually hinder students, especially those in low-middle income countries (LMICs), from seeking mental health interventions. Hence, it is necessary to identify effective, affordable and sustainable counter-stress measures for college students in the LMICs context. This study examines the sustained effects of mindfulness practice on the psychological outcomes and brain activity of students.
Racial and Ethnic discrimination effects on adolescent mental health.
Content examines the health and wellbeing of healthcare assistants vs non-healthcare assistants during the COVID-19 pandemic. Ties with goal on educating all about mental health and working towards health and wellbeing for all.
The article looks at the effects on mental health when accessibility was limited during COVID-19 containment policies.
Focused on mental health of young people and how it was impacted by the COVID-19 pandemic. Links to good health and wellbeing for all.
This study explores the current status and problems of breast cancer treatment with schizophrenia, including advanced stage diagnosis. It finds that patients with schizophrenia with reduced ADL are less likely to receive chemotherapy or recommended cancer treatment, and as such it is highly recommended that they breast cancer screening so that they can be diagnosed early and treated adequately.
This review highlights the role of liposomes in delivering drugs across blood-brain barrier which has been seen to reducing the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD).
Immunogenicity in each study group. Immunogenicity (anti-RBD IgG response) was measured by ELISA and reported in RLU (relative luminescence units) normalized to CR3022.
COVID-19 vaccine efficacy has been evaluated in large clinical trials and in real-world situation. Although they have proven to be very effective in the general population, little is known about their efficacy in immunocompromised patients.

Pages